Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Metis Health Analytics
Metis Health Analytics

Metis Health Analytics

Angel

METIS Health Analytics: NC-based software firm using AI to optimize safety and quality of CT scans.

HQ
Chapel Hill, NC, US
Founded
2017
Overview
Compare
Fundraising
Employees

Metis Health Analytics, based in Chapel Hill, North Carolina, is dedicated to enhancing the safety and quality of medical imaging through advanced software solutions. The company leverages machine learning algorithms to monitor radiation doses and image quality in computed tomography (CT) scans. Their platform aims to ensure that patients receive the safest procedures while enabling medical practitioners to achieve the necessary image quality for accurate diagnoses.

Metis Health Analytics has developed the first system capable of measuring medical image quality and radiation dose at the organ level in individual patient images. This innovative approach has positioned them as a leader in the medical imaging field, significantly impacting patient safety and diagnostic accuracy.

Metis Health Analytics - Similar Companies

AI Metrics logo

AI Metrics

aimetrics.com

Imalogix logo

Imalogix

imalogix.com

Ambient Clinical Analytics logo

Ambient Clinical Analytics

Quantivly logo

Quantivly

quantivly.com

BioSignal Analytics logo

BioSignal Analytics

Gradient Health logo

Gradient Health

gradienthealth.ai

Configo Health logo

Configo Health

configohealth.com

Health Data Analytics Institute logo

Health Data Analytics Institute

hda-institute.com

RadLogics logo

RadLogics

radlogics.com

Hippocratic AI logo

Hippocratic AI

hippocraticai.com

HealthReveal logo

HealthReveal

Qualmetrix logo

Qualmetrix

qualmetrix.com

Foresite Healthcare logo

Foresite Healthcare

Quantaras logo

Quantaras

quantaras.com

Clairity logo

Clairity

Metis Health Analytics - Quick Facts

Who are Metis Health Analytics' competitors?

Companies similar to Metis Health Analytics include AI Metrics, Imalogix, Ambient Clinical Analytics and Quantivly.

When was Metis Health Analytics founded?

Metis Health Analytics was founded in 2017.

Where is Metis Health Analytics' headquarters located?

Metis Health Analytics' headquarters is located in Chapel Hill, NC, US.

When was Metis Health Analytics' last funding round?

Metis Health Analytics' most recent funding round was for $75k (USD) in September 2022.

How much has Metis Health Analytics raised to-date?

As of Sep 22, 2022, Metis Health Analytics has raised a total of $75k (USD).

How many employees does Metis Health Analytics have?

Metis Health Analytics has 50 employees as of Feb 4, 2024.

Metis Health Analytics - Classification

Ownership
  • Private
Technology
  • AI
  • Machine Learning
Geographic Exposure
  • United States
Model
  • Platform
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Analytics
  • Software
Tags
  • Healthtech
  • SaaS
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 5 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7372Prepackaged Software